Sodium Hydroxide → HCID 53967500, compound
Reaction equation
C[O:2][C:3](=[O:50])[C@H:4]([CH2:21][C:22]1[CH:27]=[CH:26][C:25]([N:28]2[C:32](=[O:33])[CH:31]([CH2:34][C:35]3[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=3)[N:30]([C:41](=[O:43])[CH3:42])[CH:29]2[C:44]2[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=2)=[CH:24][CH:23]=1)[NH:5][C:6]([C:8]1([CH2:13][CH2:14][CH2:15][CH2:16][S:17]([CH3:20])(=[O:19])=[O:18])[CH2:12][CH2:11][CH2:10][CH2:9]1)=[O:7].[OH-].[Na+]>CCO.CC(O)=O>[C:41]([N:30]1[CH:31]([CH2:34][C:35]2[CH:36]=[CH:37][CH:38]=[CH:39][CH:40]=2)[C:32](=[O:33])[N:28]([C:25]2[CH:26]=[CH:27][C:22]([CH2:21][C@@H:4]([C:3]([OH:50])=[O:2])[NH:5][C:6]([C:8]3([CH2:13][CH2:14][CH2:15][CH2:16][S:17]([CH3:20])(=[O:18])=[O:19])[CH2:9][CH2:10][CH2:11][CH2:12]3)=[O:7])=[CH:23][CH:24]=2)[CH:29]1[C:44]1[CH:45]=[CH:46][CH:47]=[CH:48][CH:49]=1)(=[O:43])[CH3:42]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
4-(3-acetyl-5-oxo-2-phenyl-4-phenylmethyl-1-imidazolidinyl)-N-[[1-[4-(methylsulfonyl)butyl]cyclopentyl]carbonyl]-L-phenylalanine methyl ester diastereomer 1(90 mg, 0.128 mmol) in EtOH (3 mL) was treated with NaOH (1N, 0.3 mL) at room temperature for 30 min. The resulting solution was acidified with 1 drop of HOAc and was purified by HPLC (C-18, linear gradent from 5% acetonitrile to 95% in water over 30 min) to give 84 mg (95%, 0.122 mmol) of 4-(3-acetyl-5-oxo-2-phenyl-4-phenylmethyl-1-imidazolidinyl)-N-[[1-[4-(methyl-sulfonyl)butyl]cyclopentyl]carbonyl]-L-phenylalanine diastereomer 1. LR MS: 688 (M+H).
Workup
- customwas purified by HPLC (C-18, linear gradent from 5% acetonitrile to 95% in water over 30 min)
Sources & evidence
- ORD record
- ord-3716b860dbdd4e52a768d5be49c3535d
- Source dataset
- uspto-grants-2004_10
- Patent number
- US06806365B2
Reaction notes
Loading…